Delta 9 Cannabis (CVE:NINE) Stock Price Up 3% – Should You Buy?

Delta 9 Cannabis Inc (CVE:NINE)’s stock price shot up 3% during mid-day trading on Monday . The stock traded as high as C$1.13 and last traded at C$1.03. 68,728 shares were traded during mid-day trading, a decline of 41% from the average session volume of 117,300 shares. The stock had previously closed at C$1.00.

Delta 9 Cannabis Stock Up 3.0%

The company has a debt-to-equity ratio of 33.00, a quick ratio of 2.04 and a current ratio of 4.44. The business has a 50 day simple moving average of C$1.03 and a 200-day simple moving average of C$1.03. The firm has a market capitalization of C$89.36 million and a price-to-earnings ratio of 19.07.

About Delta 9 Cannabis

Delta 9 Cannabis Inc operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc, engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers. It also owns and operates retail cannabis store in Winnipeg, Manitoba, as well as cannabis superstore in Brandon, Manitoba. The company operates its retail stores under the Delta 9 Cannabis Store brand name.